Lifestyle and dietary risk factors for peripheral artery disease

Circulation Journal

Volumn 78, Issue 3, 2014, Pages 553-559

  Ruiz Canela, Miguel ^a   Martínez González, Miguel A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Mediterranean diet; Peripheral artery disease; Prevention

Indexed keywords

25 HYDROXYVITAMIN D; 4, 4' ISOPROPYLIDENEDIPHENOL; ADIPONECTIN; ALPHA TOCOPHEROL; ASCORBIC ACID; BILIRUBIN; C REACTIVE PROTEIN; CYANOCOBALAMIN; FIBRINOGEN; FLAVONOID; FOLIC ACID; HYDROXYTYROSOL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; ORGANOCHLORINE PESTICIDE; PHOSPHOLIPASE A2; POLYPHENOL; POLYUNSATURATED FATTY ACID; PYRIDOXINE; UNCLASSIFIED DRUG; VITAMIN D; FAT INTAKE; VITAMIN;

ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DIETARY FIBER; DNA POLYMORPHISM; FAT INTAKE; FRAMINGHAM RISK SCORE; HORMONE SUBSTITUTION; HUMAN; LEUKOCYTE COUNT; LIFESTYLE MODIFICATION; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SMOKING CESSATION; SYSTEMATIC REVIEW (TOPIC); FEMALE; FOOD PREFERENCE; LIFESTYLE; MALE; METABOLISM; PERIPHERAL ARTERIAL DISEASE;

ANKLE BRACHIAL INDEX; DIET, MEDITERRANEAN; DIETARY FATS; FEMALE; FOOD PREFERENCES; HUMANS; LIFE STYLE; MALE; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; VITAMINS;

EID: 84894419165     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0062     Document Type: Review

References (101)

1. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 58: 2020-2045.
2. Peach G, Griffin M, Jones KG, Thompson MM, Hinchliffe RJ. Diagnosis and management of peripheral arterial disease. BMJ 2012; 345: e5208, doi:10.1136/bmj.e5208.
3. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2851-2906.
4. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239-1312.
5. Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease, Creager MA, Belkin M, Bluth EI, Casey DE Jr, Chaturvedi S, et al. 2012 ACCF/AHA/ACR/SCAI/SIR/ STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation 2012; 125: 395-467.
6. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013; 382: 1329-1340.
7. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association. Circulation 2012; 126: 2890-2909.
8. Dachun X, Jue L, Liling Z, Yawei X, Dayi H, Pagoto SL, et al. Sensitivity and specificity of the ankle--brachial index to diagnose peripheral artery disease: A structured review. Vasc Med 2010; 15: 361-369.
9. Xu D, Zou L, Xing Y, Hou L, Wei Y, Zhang J, et al. Diagnostic value of ankle-brachial index in peripheral arterial disease: A meta-analysis. Can J Cardiol 2013; 29: 492-498.
10. Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg 2011; 41: 110-116.
11. Hoyer C, Sandermann J, Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg 2013; 58: 231-238.
12. Klein S, Hage JJ. Measurement, calculation, and normal range of the ankle-arm index: A bibliometric analysis and recommendation for standardization. Ann Vasc Surg 2006; 20: 282-292.
13. Lange SF, Trampisch HJ, Pittrow D, Darius H, Mahn M, Allenberg JR, et al. Profound influence of different methods for determination of the ankle brachial index on the prevalence estimate of peripheral arterial disease. BMC Public Health 2007; 7: 147, doi:10.1186/1471- 2458-7-147.
14. Schroder F, Diehm N, Kareem S, Ames M, Pira A, Zwettler U, et al. A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease. J Vasc Surg 2006; 44: 531-536.
15. Allison MA, Aboyans V, Granston T, McDermott MM, Kamineni A, Ni H, et al. The relevance of different methods of calculating the anklebrachial index: The Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2010; 171: 368-376.
16. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: Data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 2007; 55: 583-589.
17. Ford ES, Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: Public health versus clinical care. Annu Rev Public Health 2011; 32: 5-22.
18. Hirsch AT, Duval S. The global pandemic of peripheral artery disease. Lancet 2013; 382: 1312-1314.
19. Alzamora MT, Fores R, Baena-Diez JM, Pera G, Toran P, Sorribes M, et al. The peripheral arterial disease study (PERART/ARTPER): Prevalence and risk factors in the general population. BMC Public Health 2010; 10: 38, doi:10.1186/1471-2458-10-38.
20. Blanes JI, Cairols MA, Marrugat J. Prevalence of peripheral artery disease and its associated risk factors in Spain: The ESTIME Study. Int Angiol 2009; 28: 20-25.
21. Aponte J. The prevalence of asymptomatic and symptomatic peripheral arterial disease and peripheral arterial disease risk factors in the U.S. population. Holist Nurs Pract 2011; 25: 147-161.
22. Eraso LH, Fukaya E, Mohler ER 3rd, Xie D, Sha D, Berger JS. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol 2012 June 27, doi:10.1177/2047487312452968 [E-pub ahead of print].
23. He M, Qin X, Cui Y, Cai Y, Sun L, Xu X, et al. Prevalence of unrecognized lower extremity peripheral arterial disease and the associated factors in chinese hypertensive adults. Am J Cardiol 2012; 110: 1692-1698.
24. Berger JS, Hochman J, Lobach I, Adelman MA, Riles TS, Rockman CB. Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories. J Vasc Surg 2013; 58: 673-681.
25. Teodorescu V, Vavra A, Kibbe M. Peripheral arterial disease in women. J Vasc Surg 2013; 57(Suppl): 18S-26S.
26. Rockman CB, Maldonado TS, Jacobowitz GR, Adelman MA, Riles TS. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women. Ann Vasc Surg 2012; 26: 411-418.
27. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, et al. A call to action: Women and peripheral artery disease: A scientific statement from the American Heart Association. Circulation 2012; 125: 1449-1472.
28. Singh S, Bailey KR, Kullo IJ. Ethnic differences in ankle brachial index are present in middle-aged individuals without peripheral arterial disease. Int J Cardiol 2013; 162: 228-233.
29. Inglis S, Hermis A, Shehab S, Newton P, Lal S, Davidson P. Peripheral arterial disease and chronic heart failure: A dangerous mix. Heart Fail Rev 2013; 18: 457-464.
30. Brevetti G, Schiano V, Verdoliva S, Silvestro A, Sirico G, De Maio J, et al. Peripheral arterial disease and cardiovascular risk in Italy: Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. J Cardiovasc Med (Hagerstown) 2006; 7: 608-613.
31. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: Morbidity and mortality implications. Circulation 2006; 114: 688-699.
32. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053-2061.
33. Cimminiello C, Kownator S, Wautrecht JC, Carvounis CP, Kranendonk SE, Kindler B, et al. The PANDORA study: Peripheral arterial disease in patients with non-high cardiovascular risk. Intern Emerg Med 2011; 6: 509-519.
34. Alzamora MT, Fores R, Pera G, Torán P, Heras A, Sorribes M, et al. Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort. BMC Cardiovasc Disord 2013; 13: 119, doi:10.1186/1471-2261-13- 119.
35. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008; 300: 197-208.
36. Aboyans V, McClelland RL, Allison MA, McDermott MM, Blumenthal RS, Macura K, et al. Lower extremity peripheral artery disease in the absence of traditional risk factors: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2011; 214: 169-173.
37. Ramos R, Quesada M, Solanas P, Subirana I, Sala J, Vila J, et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009; 38: 305-311.
38. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol 2005; 25: 1463-1469.
39. Ferket BS, Spronk S, Colkesen EB, Hunink MG. Systematic review of guidelines on peripheral artery disease screening. Am J Med 2012; 125: 198-208.
40. Moyer V. U.S. Preventive Services Task Force. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013; 159: 342-348.
41. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA 2012; 308: 1660-1667.
42. Lu L, Mackay DF, Pell JP. Meta-analysis of the association between cigarette smoking and peripheral arterial disease. Heart 2013 August 6, doi:10.1136/heartjnl-2013-304082 [E-pub ahead of print].
43. Lu L, Mackay DF, Pell JP. Association between level of exposure to secondhand smoke and peripheral arterial disease: Cross-sectional study of 5,686 never smokers. Atherosclerosis 2013; 229: 273-276.
44. Vu TH, Stamler J, Liu K, McDermott MM, Lloyd-Jones DM, Pirzada A, et al. Prospective relationship of low cardiovascular risk factor profile at younger ages to ankle-brachial index: 39-year follow-up--the Chicago Healthy Aging Study. J Am Heart Assoc 2012; 1: e001545, doi:10.1161/JAHA.112.001545.
45. Garg PK, Biggs ML, Carnethon M, Ix JH, Criqui MH, Britton KA, et al. Metabolic syndrome and risk of incident peripheral artery disease: The Cardiovascular Health Study. Hypertension 2014; 63: 413-419.
46. Brostow DP, Hirsch AT, Collins TC, Kurzer MS. The role of nutrition and body composition in peripheral arterial disease. Nat Rev Cardiol 2012; 9: 634-643.
47. Melamed ML, Muntner P, Michos ED, Uribarri J, Weber C, Sharma J, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: Results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008; 28: 1179-1185.
48. Khandanpour N, Loke YK, Meyer FJ, Jennings B, Armon MP. Homocysteine and peripheral arterial disease: Systematic review and metaanalysis. Eur J Vasc Endovasc Surg 2009; 38: 316-322.
49. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008; 28: 166-172.
50. Joosten M, Joshipura K, Pai J, Bertoia M, Rimm E, Mittleman M, et al. Total adiponectin and risk of symptomatic lower extremity peripheral artery disease in men. Arterioscler Thromb Vasc Biol 2013; 33: 1092-1097.
51. Li SB, Yang F, Jing L, Ma J, Jia YD, Dong SY, et al. Correlation between plasma lipoprotein-associated phospholipase A and peripheral arterial disease. Exp Ther Med 2013; 5: 1451-1455.
52. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation 2010; 122: 1862-1875.
53. Tzoulaki I, Murray G, Lee A, Rumley A, Lowe GDO, Fowkes FGR. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J 2007; 28: 354-362.
54. Wildman RP, Muntner P, Chen J, Sutton-Tyrrell K, He J. Relation of inflammation to peripheral arterial disease in the National Health and Nutrition Examination Survey, 1999-2002. Am J Cardiol 2005; 96: 1579-1583.
55. Xu X, Hu H, Kearney GD, Kan H, Sheps DS. Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States. Sci Total Environ 2013; 461/462: 341-347.
56. Shankar A, Teppala S, Sabanayagam C. Bisphenol A and peripheral arterial disease: Results from the NHANES. Environ Health Perspect 2012; 120: 1297-1300.
57. Min JY, Cho JS, Lee KJ, Park JB, Park SG, Kim JY, et al. Potential role for organochlorine pesticides in the prevalence of peripheral arterial diseases in obese persons: Results from the National Health and Nutrition Examination Survey 1999-2004. Atherosclerosis 2011; 218: 200-206.
58. Leeper NJ, Kullo IJ, Cooke JP. Genetics of peripheral artery disease. Circulation 2012; 125: 3220-3228.
59. Berard AM, Bedel A, Le Trequesser R, Freyburger G, Nordern A, Colomer S, et al. Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: A case-control study. PLoS One 2013; 8: e37882, doi:10.1371/journal.pone.0037882.
60. Zintzaras E, Zdoukopoulos N. A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: The CUMAGAS-PAD database. Am J Epidemiol 2009; 170: 1-11.
61. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009; 204: e86-e92, doi:10.1016/j.atherosclerosis.2008.10.023
62. Aggarwal S, Loomba RS, Arora R. Preventive aspects in peripheral artery disease. Ther Adv Cardiovasc Dis 2012; 6: 53-70.
63. Khan S, Cleanthis M, Smout J, Flather M, Stansby G. Life-style modification in peripheral arterial disease. Eur J Vasc Endovasc Surg 2005; 29: 2-9.
64. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA 2002; 288: 2569-2578.
65. Hu FB. Dietary pattern analysis: A new direction in nutritional epidemiology. Curr Opin Lipidol 2002; 13: 3-9.
66. Williams CM, Lovegrove JA, Griffin BA. Dietary patterns and cardiovascular disease. Proc Nutr Soc 2013; 72: 407-411.
67. Brown AA, Hu FB. Dietary modulation of endothelial function: Implications for cardiovascular disease. Am J Clin Nutr 2001; 73: 673-686.
68. Barbaresko J, Koch M, Schulze MB, Nothlings U. Dietary pattern analysis and biomarkers of low-grade inflammation: A systematic literature review. Nutr Rev 2013; 71: 511-527.
69. Vetrani C, Costabile G, Di Marino L, Rivellese AA. Nutrition and oxidative stress: A systematic review of human studies. Int J Food Sci Nutr 2013; 64: 312-326.
70. Carrero JJ, Grimble RF. Does nutrition have a role in peripheral vascular disease? Br J Nutr 2006; 95: 217-229.
71. Grenon SM, Hughes-Fulford M, Rapp J, Conte MS. Polyunsaturated fatty acids and peripheral artery disease. Vasc Med 2012; 17: 51-63.
72. Donnan PT, Thomson M, Fowkes FG, Prescott RJ, Housley E. Diet as a risk factor for peripheral arterial disease in the general population: The Edinburgh Artery Study. Am J Clin Nutr 1993; 57: 917-921.
73. Klipstein-Grobusch K, den Breeijen JH, Grobbee DE, Boeing H, Hofman A, Witteman JC. Dietary antioxidants and peripheral arterial disease: The Rotterdam Study. Am J Epidemiol 2001; 154: 145-149.
74. Antonelli-Incalzi R, Pedone C, McDermott MM, Bandinelli S, Miniati B, Lova RM, et al. Association between nutrient intake and peripheral artery disease: Results from the InCHIANTI study. Atherosclerosis 2006; 186: 200-206.
75. Gimeno SG, Hirai AT, Harima HA, Kikuchi MY, Simony RF, de Barros N Jr, et al. Fat and fiber consumption are associated with peripheral arterial disease in a cross-sectional study of a Japanese- Brazilian population. Circ J 2008; 72: 44-50.
76. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008; 102: 1540-1544.
77. Lane JS, Magno CP, Lane KT, Chan T, Hoyt DB, Greenfield S. Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg 2008; 48: 897-904.
78. Naqvi AZ, Davis RB, Mukamal KJ. Dietary fatty acids and peripheral artery disease in adults. Atherosclerosis 2012; 222: 545-550.
79. Sugiura T, Yoshikawa D, Ishii H, Suzuki S, Kumagai S, Inoue Y, et al. Relation of omega-3 fatty acid and C-reactive protein to peripheral artery disease in patients with coronary artery disease. Heart Vessels 2013 June 26, doi:10.1007/s00380-013-0384-4 [E-pub ahead of print].
80. Naqvi AZ, Davis RB, Mukamal KJ. Nutrient intake and peripheral artery disease in adults: Key considerations in cross-sectional studies. Clin Nutr 2013 July 3, doi:10.1016/j.clnu.2013.06.011.
81. Katsouyanni K, Skalkidis Y, Petridou E, Polychronopoulou- Trichopoulou A, Willett W, Trichopoulos D. Diet and peripheral arterial occlusive disease: The role of poly-, mono-, and saturated fatty acids. Am J Epidemiol 1991; 133: 24-31.
82. Leng GC, Horrobin DF, Fowkes FG, Smith FB, Lowe GD, Donnan PT, et al. Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease: A population-based casecontrol study. Arterioscler Thromb 1994; 14: 471-478.
83. Ciccarone E, Di Castelnuovo A, Salcuni M, Siani A, Giacco A, Donatti MB, et al. A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes. J Thromb Haemost 2003; 1: 1744-1752.
84. Lagiou P, Samoli E, Lagiou A, Skalkidis Y, Katsouyanni K, Petridou E, et al. Flavonoid classes and risk of peripheral arterial occlusive disease: A case-control study in Greece. Eur J Clin Nutr 2006; 60: 214-219.
85. Wilmink AB, Welch AA, Quick CR, Burns PJ, Hubbard CS, Bradbury AW, et al. Dietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. J Vasc Surg 2004; 39: 513-516.
86. Tornwall ME, Virtamo J, Haukka JK, Aro A, Albanes D, Huttunen JK. Prospective study of diet, lifestyle, and intermittent claudication in male smokers. Am J Epidemiol 2000; 151: 892-901.
87. Hung HC, Merchant A, Willett W, Ascherio A, Rosner BA, Rimm E, et al. The association between fruit and vegetable consumption and peripheral arterial disease. Epidemiology 2003; 14: 659-665.
88. Merchant AT, Hu FB, Spiegelman D, Willett WC, Rimm EB, Ascherio A. The use of B vitamin supplements and peripheral arterial disease risk in men are inversely related. J Nutr 2003; 133: 2863-2867.
89. Merchant AT, Hu FB, Spiegelman D, Willett WC, Rimm EB, Ascherio A. Dietary fiber reduces peripheral arterial disease risk in men. J Nutr 2003; 133: 3658-3663.
90. Ruiz-Canela M, Estruch R, Corella D, Salas-Salvadó J, Martínez- González MA. Association of Mediterranean diet with peripheral artery disease: The PREDIMED randomized trial. JAMA 2014; 311: 415-417.
91. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, Polychronopoulos E, et al. Diet and overall survival in elderly people. BMJ 1995; 311: 1457-1460.
92. Martínez-González MA, Bes-Rastrollo M. Dietary patterns, Mediterranean diet, and cardiovascular disease. Curr Opin Lipidol 2014; 25: 20-26.
93. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean Diet. N Engl J Med 2013; 368: 1279-1290.
94. Urpi-Sarda M, Casas R, Chiva-Blanch G, Romero-Mamani ES, Valderas-Martínez P, Arranz S, et al. Virgin olive oil and nuts as key foods of the Mediterranean diet effects on inflammatory biomarkers related to atherosclerosis. Pharmacol Res 2012; 65: 577-583.
95. Scoditti E, Calabriso N, Massaro M, Pellegrino M, Storelli C, Martines G, et al. Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch Biochem Biophys 2012; 527: 81-89.
96. Marin C, Ramirez R, Delgado-Lista J, Yubero-Serrano EM, Perez- Martinez P, Carracedo J, et al. Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium. Am J Clin Nutr 2011; 93: 267-274.
97. Martin-Pelaez S, Covas MI, Fito M, Kusar A, Pravst I. Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims. Mol Nutr Food Res 2013; 57: 760-771.
98. Ruiz-Canela M, Martinez-Gonzalez MA. Olive oil in the primary prevention of cardiovascular disease. Maturitas 2011; 68: 245-250.
99. Nordmann AJ, Suter-Zimmermann K, Bucher HC, Shai I, Tuttle KR, Estruch R, et al. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med 2011; 124: 841-851.
100. McManus K, Antinoro L, Sacks F. A randomized controlled trial of a moderate-fat, low-energy diet compared with a low fat, low-energy diet for weight loss in overweight adults. Int J Obes Relat Metab Disord 2001; 25: 1503-1511.
101. Scholl J. Traditional dietary recommendations for the prevention of cardiovascular disease: Do they meet the needs of our patients? Cholesterol 2012; 2012: 367-898, doi:10.1155/2012/367898.